Kasthuri RS - Search Results

1

Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia A.

Chen SL, Ellsworth P, Kasthuri RS, Moll S, Ma AD, Key NS. Chen SL, et al. Among authors: kasthuri rs. Haemophilia. 2021 Jul;27(4):e585-e588. doi: 10.1111/hae.14335. Epub 2021 May 29. Haemophilia. 2021. PMID: 34050698 No abstract available.

2

Potential biomarkers of an exaggerated response to endotoxemia.

Kasthuri RS, Wroblewski M, Jilma B, Key NS, Nelsestuen GL. Kasthuri RS, et al. Biomarkers. 2007 May-Jun;12(3):287-302. doi: 10.1080/13547500601160536. Biomarkers. 2007. PMID: 17453742

3

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.

Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N. Manly DA, et al. Thromb Res. 2010 Jun;125(6):511-2. doi: 10.1016/j.thromres.2009.09.019. Epub 2009 Oct 24. Thromb Res. 2010. PMID: 19854471 Free PMC article.

4

Current treatment of venous thromboembolism.

Key NS, Kasthuri RS. Key NS, et al. Among authors: kasthuri rs. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):372-5. doi: 10.1161/ATVBAHA.109.197145. Epub 2010 Feb 5. Arterioscler Thromb Vasc Biol. 2010. PMID: 20139364 Free PMC article. Review.

5

Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia.

Boles JC, Key NS, Kasthuri R, Ma AD. Boles JC, et al. J Thromb Haemost. 2011 Jul;9(7):1429-31. doi: 10.1111/j.1538-7836.2011.04345.x. J Thromb Haemost. 2011. PMID: 21575131 Free article. No abstract available.

6

Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.

Boles JC, Williams JC, Hollingsworth RM, Wang JG, Glover SL, Owens AP 3rd, Barcel DA, Kasthuri RS, Key NS, Mackman N. Boles JC, et al. Among authors: kasthuri rs. Thromb Res. 2012 Feb;129(2):197-203. doi: 10.1016/j.thromres.2011.06.022. Epub 2011 Jul 16. Thromb Res. 2012. PMID: 21762960

7

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.

Kasthuri RS, Glover SL, Jonas W, McEachron T, Pawlinski R, Arepally GM, Key NS, Mackman N. Kasthuri RS, et al. Blood. 2012 May 31;119(22):5285-93. doi: 10.1182/blood-2011-06-359430. Epub 2012 Mar 6. Blood. 2012. PMID: 22394597 Free PMC article. Clinical Trial.

8

Medical management of venous thromboembolism: what the interventional radiologist needs to know.

Kasthuri RS, Key NS. Kasthuri RS, et al. Semin Intervent Radiol. 2012 Mar;29(1):3-9. doi: 10.1055/s-0032-1302445. Semin Intervent Radiol. 2012. PMID: 23449379 Free PMC article.

9

Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.

Lim MY, Nielsen B, Lee K, Kasthuri RS, Key NS, Ma AD. Lim MY, et al. Among authors: kasthuri rs. J Thromb Haemost. 2014 Jun;12(6):897-901. doi: 10.1111/jth.12579. J Thromb Haemost. 2014. PMID: 24702722 Free article.

10

Excess of heme induces tissue factor-dependent activation of coagulation in mice.

Sparkenbaugh EM, Chantrathammachart P, Wang S, Jonas W, Kirchhofer D, Gailani D, Gruber A, Kasthuri R, Key NS, Mackman N, Pawlinski R. Sparkenbaugh EM, et al. Haematologica. 2015 Mar;100(3):308-14. doi: 10.3324/haematol.2014.114728. Epub 2015 Jan 16. Haematologica. 2015. PMID: 25596265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page